Skip to main content

Table 2 List of genes with the corresponding PDAVs that were validated as true positive in the corresponding BC patient

From: Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families

Gene

Variant type

Transcript: Base change (Protein change)

Exon (Intron)

MAF 1000 g [gnomAD]

rsID (dbsnp147)

BC Patients

Controls

ABCC11

splice-site substitution

NM_032583.3:c.395 + 2 T > C (p.?)

4

− [0.000004061]

BB44

0

ABCC11

nonsense substitution

NM_032583.3:c.297G > A (p.Trp99*)

4

− [0.0007676]

rs145048685

BB12

1x

BARD1

nonsense substitution

NM_000465.3:c.1690C > T (p.Gln564*)

8

− [0.00002032]

rs587780021

BB13

0

BBS10

frameshift insertions

NM_024685.3:c.271dup (p.Cys91Leufs*5)

2

− [0.0005626]

rs549625604

BB15 **

1x

BBS10

frameshift insertions

NM_024685.3:c.1543_1546dup (p.Thr516Argfs*7)

2

− [−]

BB48

0

CCNH

frameshift deletion

NM_001239.3:c.643_646del (p.Thr215Profs*21)

5

− [0.000008149]

BB15**

0

CD96

frameshift insertions

NM_198196.2:c.766dup (p.Ile256Asnfs*13)

5

− [0.00001625]

rs766366613

BB10

0

CD96

nonsense substitution

NM_198196.2:c.1321C > T (p.Arg441*)

11

− [0.0001056]

rs201691670

BB54**

0

CHEK2

frameshift deletion

NM_001005735.1:c.1229del (p.Thr410Metfs*15)

12

0.001 [0.002077]

rs555607708

BB17

0

CYP1A1

frameshift deletion

NM_000499.3:c.1371del (p.Cys457*)

7

0.0006 [0.0009096]

rs561096394

BB1

0

DCLRE1A

nonsense substitution

NM_001271816.1:c.412C > T (p.Arg138*)

2

0.002 [0.00279]

rs41292634

BB41

0

DCLRE1C

nonsense substitution

NM_001033855.2:c.241C > T (p.Arg81*)

3

− [0.00001221]

rs121908156

BB33***

0

DHCR7

splice-site substitution

NM_001360.2::c.964-1G > C (p.?)

9(8)

0.0026 [0.003762]

rs138659167

BB21

0

DNAH11

frameshift deletion

NM_001277115.1:c.2081_2082del (p.Val694Glyfs*2)

12

− [−]

BB29**

0

ESCO2

frameshift deletion

NM_001017420.2:c.876_879del (p.Asp292Glufs*48)

4

− [0.00000409]

rs80359856

BB35**

0

EXO1

splice-site substitution

NM_006027.4:c.2212-1G > C (p.?)

13(12)

0.0012 [0.001644]

rs4150000

BB35**

0

FANCA

splice-site substitution

NM_000135.2:c.2152-2A > G (p.?)

24(23)

− [−]

BB45

0

FLT4

nonsense substitution

NM_182925.4:c.3048C > A (p.Cys1016*)

22

− [−]

BB38

0

HPS6

stop-loss substitution

NM_024747.5:c.2326 T > C (p.*776Argext*38)

1

− [0.0001577]

rs200206362

BB33***

0

MUS81

nonsense substitution

NM_025128.4:c.392G > A (p.Trp131*)

4

− [0]

BB7

0

MYH8

nonsense substitution

NM_002472.2:c.1209C > A (p.Cys403*)

13

0.0004 [0.001105]

rs144321381

BB31

0

NME8

splice-site substitution

NM_016616.4:c.454 + 1G > A (p.?)

8

− [0.00006108]

rs538425312

BB3**

0

NME8

nonsense substitution

NM_016616.4:c.1600C > T (p.Arg534*)

17

0.0008 [0.0003171]

rs142525551

BB33***

0

PALB2

frameshift insertions

NM_024675.3:c.1674dup (p.Gln559Serfs*19)

4

− [−]

BB36

0

PDE11A

frameshift deletion

NM_016953.3:c.1660del (p.Cys554Valfs*14)

9

0.0008 [0.001214]

rs573163079

BB5

1x

RAD51C

frameshift deletion

NM_058216.2:c.181_182del (p.Leu61Alafs*11)

2

− [0.00001624]

rs754525165

BB54**

0

RECQL4

frameshift deletion

NM_004260.3:c.1573del (p.Cys525Alafs*33)

9

− [0.0002387]

rs386833845

BB52

0

RECQL4

frameshift deletion

NM_004260.3:c.3439del (p.Leu1147Cysfs*3)

20

− [−]

BB34

0

RINT1

nonsense substitution

NM_021930.4:c.64G > T (p.Glu22*)

2

− [−]

BB3**

0

TDP1

frameshift deletion

NM_018319.3:c.502del (p.Leu168Serfs*45)

3

− [0.00002039]

rs762302264

BB32

0

TTC8

nonsense substitution

NM_001288781.1:c.736C > T (p.Gln246*)

9

− [−]

BB29**

0

  1. In addition to the details of each variant (variant type, transcript ID, base change, protein change, exon/intron), its frequency in controls, dbsnp147, global MAF in 1000 genome [2015 August release] and gnomAD [Ensembl GRCh37 release 95] are also given. ** = BC patient with PDAV in two genes, *** = BC patient with PDAV in three genes and “−” = not available